AU6403600A - Methods and compositions for treating urinary frequency and urgency using optically pure (s)-oxybutynin - Google Patents

Methods and compositions for treating urinary frequency and urgency using optically pure (s)-oxybutynin

Info

Publication number
AU6403600A
AU6403600A AU64036/00A AU6403600A AU6403600A AU 6403600 A AU6403600 A AU 6403600A AU 64036/00 A AU64036/00 A AU 64036/00A AU 6403600 A AU6403600 A AU 6403600A AU 6403600 A AU6403600 A AU 6403600A
Authority
AU
Australia
Prior art keywords
oxybutynin
urgency
compositions
methods
optically pure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU64036/00A
Inventor
Paul D. Rubin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sepracor Inc
Original Assignee
Sepracor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US32969699A priority Critical
Priority to US09329696 priority
Application filed by Sepracor Inc filed Critical Sepracor Inc
Priority to PCT/US2000/040183 priority patent/WO2000076490A2/en
Publication of AU6403600A publication Critical patent/AU6403600A/en
Application status is Abandoned legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
AU64036/00A 1999-06-10 2000-06-09 Methods and compositions for treating urinary frequency and urgency using optically pure (s)-oxybutynin Abandoned AU6403600A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US32969699A true 1999-06-10 1999-06-10
US09329696 1999-06-10
PCT/US2000/040183 WO2000076490A2 (en) 1999-06-10 2000-06-09 Methods and compositions for treating urinary frequency and urgency using optically pure (s)-oxybutynin

Publications (1)

Publication Number Publication Date
AU6403600A true AU6403600A (en) 2001-01-02

Family

ID=23286590

Family Applications (1)

Application Number Title Priority Date Filing Date
AU64036/00A Abandoned AU6403600A (en) 1999-06-10 2000-06-09 Methods and compositions for treating urinary frequency and urgency using optically pure (s)-oxybutynin

Country Status (2)

Country Link
AU (1) AU6403600A (en)
WO (1) WO2000076490A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8377956B2 (en) 2010-03-01 2013-02-19 Xenoport, Inc. Use of (3R)-4-{[(1S)-2-methyl-1-(2-methylpropanoyloxy)propoxy]carbonylamino}-3-(4-chlorophenyl) butanoic acid for treating urinary incontinence

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04273818A (en) * 1991-02-28 1992-09-30 Kissei Pharmaceut Co Ltd Percutaneous administration preparation
JP2665858B2 (en) * 1992-05-30 1997-10-22 日本ヘキスト・マリオン・ルセル株式会社 Sustained release oxybutynin hydrochloride formulations
US5736577A (en) * 1995-01-31 1998-04-07 Sepracor, Inc. Methods and compositions for treating urinary incontinence using optically pure (S)-oxybutynin
US5532278A (en) * 1995-01-31 1996-07-02 Sepracor, Inc. Methods and compositions for treating urinary incontinence using optically pure (S)-oxybutynin
US5601839A (en) * 1995-04-26 1997-02-11 Theratech, Inc. Triacetin as a penetration enhancer for transdermal delivery of a basic drug
US5674895A (en) * 1995-05-22 1997-10-07 Alza Corporation Dosage form comprising oxybutynin
US6171298B1 (en) * 1996-05-03 2001-01-09 Situs Corporation Intravesical infuser
AR018321A1 (en) * 1998-03-26 2001-11-14 Alza Corp A dosage form comprising extended release oxybutynin and oxybutynin uses and dosage form liberacionprolongada.

Also Published As

Publication number Publication date
WO2000076490A2 (en) 2000-12-21
WO2000076490A3 (en) 2002-03-21

Similar Documents

Publication Publication Date Title
AU772917C (en) Stent device and method for treating glaucoma
EP1157707B8 (en) Method and composition for deforming soft tissues
AU2001261474A1 (en) Compositions and methods for the treatment of cancer
AU2002229075A1 (en) Agents and methods for treating pain
AU2002316411A1 (en) Methods and apparatus for supporting group communications
AU2730900A (en) Wood treatment process
AU2458001A (en) Method for treating inflammation
EP1231887A4 (en) Method and composition for the treatment of scars
NZ514350A (en) Compositions and methods for effecting the levels of cholesterol
AU5165000A (en) Portable disinfection and filtration system
AU5347799A (en) Keratome
AU5081298A (en) Surgical method and composition therefor
AU5807400A (en) Implant
AUPR105400A0 (en) Processes and compositions for water treatment
AU5898599A (en) Methods and compositions for genomic modification
AU1144201A (en) Implant for osteosyntheses
AU7963200A (en) Improved method and apparatus for water treatment
AU2593900A (en) Composition and method for treating glaucoma
AU4653999A (en) Exposure method and system
AU2001286576A1 (en) Composition and method for treatment of hypertriglyceridemia
AU5483000A (en) System and method for refining liposuctioned adipose tissue
AU2001256970A1 (en) Method of treatment using ligand-immunogen conjugates
AU2855700A (en) Methods and apparatus for brokering transactions
AU6232100A (en) Surgical scanning system and process for use thereof
AU2002367397A1 (en) Method and apparatus for improved vascular related treatment

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase